Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study

Journal of Rheumatology

Volumn 32, Issue 10, 2005, Pages 1893-1898

  Iannone, Florenzo ^a   Matucci Cerinic, Marco ^b   Falappone, Paola Chiara Francesca ^a   Guiducci, Serena ^c   Cinelli, Marina ^c   Distler, Oliver ^d   Lapadula, Giovanni ^a,e  

^a UNIVERSITY OF BARI   (Italy)

^b Department of Rheumatology ^*

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e Rheumatology Unit DIMIMP   (Italy)

Author keywords

integrins; 1 integrin; 3 integrin; CD44; Extracellular matrix; Systemic sclerosis

Indexed keywords

ALPHA1 INTEGRIN; ALPHA2 INTEGRIN; ALPHA3 INTEGRIN; ALPHA4 INTEGRIN; ALPHA5 INTEGRIN; ALPHA6 INTEGRIN; AZATHIOPRINE; BETA1 INTEGRIN; BETA3 INTEGRIN; CD51 ANTIGEN; CELL ADHESION MOLECULE; COLLAGEN; CYCLOPHOSPHAMIDE; HERMES ANTIGEN; INTEGRIN; PROSTAGLANDIN;

ADOLESCENT; ADULT; ARTICLE; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; FIBROSIS; FLOW CYTOMETRY; HAND; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PATHOGENESIS; PILOT STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SKIN BIOPSY; SKIN FIBROBLAST; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS;

ANTIGENS, CD44; CELLS, CULTURED; DOWN-REGULATION; EXTRACELLULAR MATRIX; FIBROBLASTS; INTEGRINS; PILOT PROJECTS; RECEPTORS, COLLAGEN; RECEPTORS, FIBRONECTIN; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED; SKIN;

EID: 26444475848     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Takehara K. Hypothesis: pathogenesis of systemic sclerosis. J Rheumatol 2003;30:755-9.
2. Morino N, Mimura T, Hamasaki K, et al. Impaired collagen gel contraction with cultured skin fibroblasts from patients with systemic sclerosis. Scand J Rheumatol 2000;29:124-6.
3. Eckes B, Mauch C, Huppe G, Krieg T. Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma. Biochem J 1996;315:549-54.
4. Damsky C, Tremble P, Werb Z. Signal transduction via the fibronectin receptor: do integrins regulate matrix remodeling? Matrix Suppl 1992;1:184-91.
5. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34.
6. Lee W, Sodek J, McCulloch CA. Role of integrins in regulation of collagen phagocytosis by human fibroblasts. J Cell Physiol 1996;168:695-704.
7. Laurent TC, Laurent UBG, Fraser JRE. Function of hyaluronan. Ann Rheum Dis 1995;54:429-32.
8. Kozlowska E, Sollberg S, Mauch C, Eckes B, Klein CE, Krieg T. Decreased expression of alpha 2 beta 1 integrin in scleroderma fibroblasts. Exp Dermatol 1996;5:57-63.
9. Osada K, Seishima M, Kitajima Y, Yaoita H, Mori S. Decreased integrin alpha 2, but normal response to TGF-beta in scleroderma fibroblasts. J Dermatol Sci 1995;9:169-75.
10. Ivarsson M, McWhirter A, Black CM, Rubin K. Impaired regulation of collagen pro-alpha 1(I) mRNA and change in pattern of collagen-binding integrins on scleroderma fibroblasts. J Invest Dermatol 1993;101:216-21.
11. Gruschwitz M, von den Driesch P, Kellner I, Hornstein OP, Sterry W. Expression of adhesion proteins involved in cell-cell and cell-matrix interactions in the skin of patients with progressive systemic sclerosis. J Am Acad Dermatol 1992;27:169-77.
12. Herzhoff K, Sollberg S, Huerkamp C, Krieg T, Eckes B. Fibroblast expression of collagen integrin receptors alpha 1 beta 1 and alpha 2 beta 1 is not changed in systemic scleroderma. Br J Dermatol 1999;141:218-23.
13. Matucci-Cerinic M, Iannone F, Carossino A, et al. Discrepant expression of neprilysin on fibroblasts in diffuse systemic sclerosis. J Rheumatol 1999;26:347-51.
14. Le Roy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
15. Szulgit G, Rudolph R, Wandel A, Tenenhaus M, Panos R, Gardner H. Alterations in fibroblast alpha 1 beta 1 integrin collagen receptor expression in keloids and hypertrophic scars. J Invest Dermatol 2002;118:409-15.
16. Noszczyk BH, Klein E, Holtkoetter O, Krieg T, Majewski S. Integrin expression in the dermis during scar formation in humans. Exp Dermatol 2002;11:311-8.
17. Ishibashi Y, Ito H, Seyama Y, Kubota S. Anti-alpha 2 integrin antibody induces secretion and activation of 72-kDa progelatinase by human fibroblasts. IUBMB Life 2001;51:25-31.
18. Dalton SL, Marcantonio EE, Assoian RK. Cell attachment controls fibronectin and alpha 5 beta 1 integrin levels in fibroblasts. Implications for anchorage-dependent and -independent growth. J Biol Chem 1992;267:8186-91.
19. Bates RC, Rankin LM, Lucas CM, Scott JL, Krissansen GW, Burns GF. Individual embryonic fibroblasts express multiple beta chains in association with the alpha v integrin subunit. Loss of beta 3 expression with cell confluence. J Biol Chem 1991;266:18593-9.
20. Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K. Increased expression levels of integrin alpha v beta 5 on scleroderma fibroblasts. Am J Pathol 2004;164:1275-92.
21. Neudecker BA, Stern R, Connolly MK. Aberrant serum hyaluronan and hyaluronidase levels in scleroderma. Br J Dermatol 2004;150:469-76.
22. Sondergaard K, Heickendorff L, Risteli L, et al. Increased levels of type I and III collagen and hyaluronan in scleroderma skin. Br J Dermatol 1997;136:47-53.
23. Majewski S, Hunzelmann N, Schirren CG, Mauch C, Aumailley M, Krieg T. Increased adhesion of fibroblasts from patients with scleroderma to extracellular matrix components: in vitro modulation by IFN-gamma but not by TGF-beta. J Invest Dermatol 1992;98:86-91.
24. Guseva NG, Anikina NV, Myllyla R, et al. Markers of collagen and basement membrane metabolism in sera of patients with progressive systemic sclerosis. Ann Rheum Dis 1991;50:481-6.